NEW YORK (GenomeWeb News) – PerkinElmer has won a contract with the Minnesota Department of Health to perform mass spectrometry-based newborn screening.

Under the terms of the contract, PerkinElmer will conduct tandem mass spec testing for 42 of 56 conditions screened for in newborns in the state, a spokesman for the health department told GenomeWeb Daily News. Minnesota had previously contracted with the Mayo Clinic for the services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.